Category: Safety

Posted on | Posted on John Murphy | Leave a Comment on Protection against Covid-19 by BNT162b2 Booster across Age Groups

Protection against Covid-19 by BNT162b2 Booster across Age Groups

Authors. Yinon M. Bar-On, M.Sc., Yair Goldberg, Ph.D., Micha Mandel, Ph.D., Omri Bodenheimer, M.Sc., Laurence Freedman, Ph.D., Sharon Alroy-Preis, M.D., Nachman Ash, M.D., Amit Huppert, Ph.D., and Ron Milo, Ph.D. Abstract BACKGROUND After promising initial results from the…[...]

Read More
Posted on | Posted on John Murphy | Leave a Comment on COVID-19 vaccination followed by activation of glomerular diseases: does association equal causation?

COVID-19 vaccination followed by activation of glomerular diseases: does association equal causation?

Authors: Nicholas L. Li,1P. Toby Coates,2 and Brad H. Rovin1,∗ Kidney Int. 2021 Nov; 100(5): 959–965.Published online 2021 Sep 14. doi: 10.1016/j.kint.2021.09.002 PMCID: PMC8437826PMID: 34534551 To date, >4 billion doses of the various severe acute respiratory syndrome…[...]

Read More
Posted on | Posted on John Murphy | Leave a Comment on Association of Myocarditis With BNT162b2 Messenger RNA COVID-19 Vaccine in a Case Series of Children

Association of Myocarditis With BNT162b2 Messenger RNA COVID-19 Vaccine in a Case Series of Children

Authors: Audrey Dionne, MD1,2; Francesca Sperotto, MD1,2; Stephanie Chamberlain1,2; et alAnnette L. Baker, MSN, CPNP1,2; Andrew J. Powell, MD1,2; Ashwin Prakash, MD1,2; Daniel A. Castellanos, MD1,2; Susan F. Saleeb, MD1,2; Sarah D. de Ferranti, MD, MPH1,2; Jane W. Newburger, MD, MPH1,2; Kevin G. Friedman, MD1,2 JAMA Cardiol. 2021;6(12):1446-1450. doi:10.1001/jamacardio.2021.347 Question  What are the findings on cardiac imaging in children with myocarditis after COVID-19…[...]

Read More
Posted on | Posted on John Murphy | Leave a Comment on The potential for antibody-dependent enhancement of SARS-CoV-2 infection: Translational implications for vaccine development

The potential for antibody-dependent enhancement of SARS-CoV-2 infection: Translational implications for vaccine development

Authors:  Jiong Wang andMartin S. Zand Published online by Cambridge University Press: 13 April 2020 Journal of Clinical and Translational Science>Volume 5 Issue 1 Abstract There is an urgent need for vaccines…[...]

Read More
Posted on | Posted on John Murphy | Leave a Comment on Worse Than the Disease? Reviewing Some Possible Unintended Consequences of the mRNA Vaccines Against COVID-19

Worse Than the Disease? Reviewing Some Possible Unintended Consequences of the mRNA Vaccines Against COVID-19

Authors: Stephanie Seneff1 and Greg Nigh Computer Science and Artificial Intelligence Laboratory, MIT, Cambridge MA, 02139, USA, E- Naturopathic Oncology, Immersion Health, Portland, OR 97214, ABSTRACT Operation Warp Speed brought…[...]

Read More
Posted on | Posted on John Murphy | Leave a Comment on Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies

Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies

Authors: Wen Shi Lee, Adam K. Wheatley, Stephen J. Kent & Brandon J. DeKosky  Nature Microbiology volume 5, pages1185–1191 (2020) Abstract Antibody-based drugs and vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are being expedited through…[...]

Read More
Posted on | Posted on John Murphy | Leave a Comment on Former Senior FDA Official: Manufacturers, FDA Negligent In Not Investigating Covid-19 Vaccine Risks To Heart Health

Former Senior FDA Official: Manufacturers, FDA Negligent In Not Investigating Covid-19 Vaccine Risks To Heart Health

Authors: DAVID GORTLER FEBRUARY 10, 2022 Manufacturers, FDA, and CDC must investigate serious cardiovascular incidents related to the Pfizer and Moderna Covid vaccines. From day ,one the U.S. Food and…[...]

Read More